Physician profile
Adonius Wright
NPI 1902105901
$971.64
in general payments reported to CMS, 2019-2025
16 companies · $55.33 in 2025
The $55.33 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $340 · 2023: $237 · 2024: $106 · 2025: $55.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.58 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $324.41 | 2021-2023 | |
| Coopersurgical, INC. | $100.52 | 2022 | |
| Organon LLC | $82.99 | 2022-2024 | Nexplanon |
| Agile Therapeutics, INC. | $81.10 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $59.80 | 2024-2025 | Veozah |
| Exeltis, USA INC. | $52.47 | 2022-2024 | Slynd |
| Millicent US INC | $47.41 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Dexcom, INC. | $43.68 | 2023 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $40.53 | 2021-2023 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $33.87 | 2022-2025 | |
| Novo Nordisk INC | $24.86 | 2023 | Wegovy |
| Therapeuticsmd, INC. | $18.09 | 2021 | |
| Sumitomo Pharma America, INC. | $17.55 | 2023 | Myfembree |
| Merck Sharp & Dohme LLC | $17.49 | 2021 | |
| Myovant Sciences INC. | $13.95 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.92 | 2023 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adonius Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.